Recurrence and Factors Associated with Recurrence in Dupuytren's Disease Patients Treated with Percutaneous Needle Aponeurotomy

Objective: Dupuytren's disease (DD) is a progressive condition of the palmar fascia that limits finger extension. Percutaneous needle aponeurotomy has become increasingly popular in recent years. Despite appropriate treatment, recurrence is common. This study investigates recurrence development following percutaneous needle aponeurotomy and evaluates the relationship between patient characteristics, disease-related factors, and recurrence in DD. Methods: This retrospective study included 98 fingers from 41 patients diagnosed with Dupuytren's disease who underwent percutaneous needle aponeurotomy at a hand surgery outpatient clinic between 2012 and 2022. Patient records were reviewed, and characteristics such as age, gender, occupation, and dominant hand were documented. The stage of DD was determined preoperatively. Functional outcomes were assessed using a subjective satisfaction scale, and postoperative complications and recurrences were analyzed. Results: Of the 41 patients, 32 (78%) were male and 9 (22%) were female. The mean age was 62 years (range, 44–82 years), and the mean follow-up period was 45 months (range, 9–138 months). Postoperative evaluations showed that 17 patients (41.5%) had excellent results, 19 patients (46.3%) had good results, and 5 patients (12.2%) had fair results. Recurrence of Dupuytren's disease occurred in 24 (58.5%) patients. Among all patients, 30 (73.2%) were willing to undergo reoperation, regardless of recurrence. The recurrence rate was significantly lower after percutaneous needle release in stage 1 DD (p = 0.011). Conclusion: Percutaneous needle aponeurotomy offers high patient satisfaction and early discharge benefits, making it a preferred option for surgeons, despite the potential for recurrence. While the classification of recurrence as a complication is debated, it is a recognized outcome of progressive DD. Regardless of patient characteristics, performing percutaneous needle aponeurotomy at an early stage can significantly reduce recurrence rates.